Cited by 461Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Resistance Mechanisms in Clinical Isolates of Candida albicans

Open access

White, Theodore C., Holleman, Scott, Dy, Francis, Mirels, Laurence F., Stevens, David A.·2002·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.46.6.1704-1713.2002PMC PMC127245

Open this paper in CoChat — free account

Abstract

Resistance to azole antifungals continues to be a significant problem in the common fungal pathogen Candida albicans . Many of the molecular mechanisms of resistance have been defined with matched sets of susceptible and resistant clinical isolates from the same strain. Mechanisms that have been identified include alterations in the gene encoding the target enzyme ERG11 or overexpression of efflux pump genes including CDR1 , CDR2 , and MDR1 . In the present study, a collection of unmatched clinical isolates of C. albicans was analyzed for the known molecular mechanisms of resistance by standard methods. The collection was assembled so that approximately half of the isolates were resistant to azole drugs. Extensive cross-resistance was observed for fluconazole, clotrimazole, itraconazole, and ketoconazole. Northern blotting analyses indicated that overexpression of CDR1 and CDR2 correlates with resistance, suggesting that the two genes may be coregulated. MDR1 overexpression was observed infrequently in some resistant isolates. Overexpression of FLU1 , an efflux pump gene related to MDR1 , did not correlate with resistance, nor did overexpression of ERG11 . Limited analysis of the ERG11 gene sequence identified several point mutations in resistant isolates; these mutations have been described previously. Two of the most common point mutations in ERG11 associated with resistance, D116E and E266D, were tested by restriction fragment length polymorphism analysis of the isolates from this collection. The results indicated that the two mutations occur frequently in different isolates of C. albicans and are not reliably associated with resistance. These analyses emphasize the diversity of mechanisms that result in a phenotype of azole resistance. They suggest that the resistance mechanisms identified in matched sets of susceptible and resistant isolates are not sufficient to explain resistance in a collection of unmatched clinical isolates and that additional mechanisms have yet to be discovered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.46.6.1704-1713.2002

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformaion of Escherichia coli
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,492
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Self-citation
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Self-citation
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470

Show all 42 references

Research works printed but not linked: 2

Holmberg, K., and D. A. Stevens. 1999. Resistance to antifungal drugs: current status and clinical implications. Curr. Opin. Anti-Infective Investig. Drugs1:306-317.
Odds F. C. 1988. Candida and Candidosis: a review and bibliography. Bailliere Tindall London United Kingdom.

Sorted by citations

Items 301–400 of 461

Association of T916C (Y257H) mutation inCandida albicans ERG11with fluconazole resistance
Zhao, J., Xu, Y., & Li, C. (2012) · Mycoses · doi:10.1111/myc.12027 · Cited by 11
NPC Natural Product Communications
Khana, S. I., Hester, J. P., Tekwania, B. L., Midiwob, J. O., Muhammada, I., Jaina, S. K., Jacoba, M. R., Walkera, L. A., Rahmana, A. A., & Samoylenkoa, V. (2011) · Cited by 11
The Role of ERG11 Point Mutations in the Resistance of Candida albicans to Fluconazole in the Presence of Lactate
Urbanek, A. K., Łapińska, Z., Derkacz, D., & Krasowska, A. (2022) · Pathogens · doi:10.3390/pathogens11111289 · Cited by 11
Vulvovaginal candidiasis in pregnant women attending a tertiary care centre in North-Eastern India
Roy, M., Majumdar, T., & Ray, J. (2024) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2024.100738 · Cited by 10
Genotypic variation and antifungal susceptibly of Candida zeylanoides clinical isolates
Shokri, H. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.01.001 · Cited by 10
Approaches to the early treatment of invasive fungal infection
Ito, J. I., Kriengkauykiat, J., Dadwal, S., Arfons, L. M., & Lazarus, H. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496504 · Cited by 10
ANTIMICROBIAL POTENTIAL OF SILVER NANOPARTICLES SYNTHESIZED USING ULVA RETICULATA
Devi, J., & Bhimba, B. V. (2014) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 10
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients
Hrabovský, V., Takáčová, V., Schréterová, E., Pastvová, L., Hrabovská, Z., Čurová, K., & Siegfried, L. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0525-8 · Cited by 10
A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts
Accoceberry, I., Rougeron, A., Biteau, N., Chevrel, P., Fitton‐Ouhabi, V., & Noël, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01483-17 · Cited by 9
Chromosome translocation induced by the insertion of the URA blaster into the major repeat sequence (MRS) in Candida albicans
Iwaguchi, S., Suzuki, M., Sakai, N., Nakagawa, Y., Magee, P. T., & Suzuki, T. (2004) · Yeast · doi:10.1002/yea.1116 · Cited by 10
Synthesis of Substituted Chalcones and Assessment of their Antifungal Activity Against Trichophyton rubrum
Zhang, K.-X., Wang, W., Zhao, F., Meng, Q., & Jin, Y. (2018) · Chemistry of Natural Compounds · doi:10.1007/s10600-018-2281-7 · Cited by 9
Menthol–thymol NADES as a fungicidal and chemosensitizing agent against multidrug-resistant Candida albicans: ROS induction, efflux pump inhibition, and synergy with fluconazole
Negro, M. F., Bustos, P. S., Bellezze, L., Ortega, M. G., Echeverría, J., Silva, M. F., & Peralta, M. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1643472 · Cited by 9
Insights into the modulatory effect of magnesium on efflux mechanisms of Candida albicans reveal inhibition of ATP binding cassette multidrug transporters and dysfunctional mitochondria
Hans, S., Fatima, Z., & Hameed, S. (2021) · BioMetals · doi:10.1007/s10534-020-00282-w · Cited by 9
Disinfection mechanism of the photocatalytic activity of SnO2 thin films against Candida albicans, proposed from experimental and simulated perspectives
Faudoa-Arzate, A., Camarillo‐Cisneros, J., Castillo-González, A. R., Favila-Pérez, M. A., Saénz-Hernández, R. J., Realyvazquez-Guevara, P. R., & Arzate-Quintana, C. (2021) · Canadian Journal of Microbiology · doi:10.1139/cjm-2020-0559 · Cited by 9
Resistance to Antifungal Agents
Arthington, B. A., & Rex, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72418-8_10 · Cited by 9
ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients
Benedetti, V. P., Savi, D. C., Aluízio, R., Adamóski, D., Kava, V. M., Galli-Terasawa, L. V., & Glienke, C. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0473-2018 · Cited by 13
Plant-Associated Endophytic Fungi and Its Secondary Metabolites Against Drug-Resistant Pathogenic Microbes
Karnam, S., Jindal, A. B., Singh, B. P., & Paul, A. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-3120-7_10 · Cited by 9
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_30 · Cited by 9
Topical Application of 4′-Hydroxychalcone in Combination with tt-Farnesol Is Effective against Candida albicans and Streptococcus mutans Biofilms
Lobo, C. I. V., Barbugli, P. A., Rocha, G. R., & Klein, M. I. (2022) · ACS Omega · doi:10.1021/acsomega.2c02318 · Cited by 8
Candida albicans mutant construction and characterization of selected virulence determinants
Motaung, T. E., Albertyn, J., Pohl, C. H., & Köhler, G. A. (2015) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2015.06.004 · Cited by 9
Per aspera ad astra: When harmful chromosomal translocations become a plus value in genetic evolution. Lessons from Saccharomyces cerevisiae.
Tosato, V., & Bruschi, C. V. (2015) · Microbial Cell · doi:10.15698/mic2015.10.230 · Cited by 8
Saliva affects the antifungal activity of exogenously added histatin 3 towardsCandida albicans
Yamagishi, H., Fitzgerald‐Hughes, D., Sein, T., Walsh, T. J., & O'Connell, B. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.01.045 · Cited by 8
Strategies to manage antifungal drug resistance
Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 8
Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile
Pinto, A. C. C., Rocha, D. A. S., de Moraes, D. C., Junqueira, M. L., & Ferreira‐Pereira, A. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920180654 · Cited by 8
Antifungal Susceptibility of Candida albicans Isolates at a Tertiary Care Hospital in Bulgaria
Hitkova, H. Y., Georgieva, D. S., Hristova, P. M., & Sredkova, M. (2019) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.92079 · Cited by 8
Synthesis, characterization, and evaluation of (E)-methyl 2-((2-oxonaphthalen-1(2H)-ylidene)methylamino)acetate as a biological agent and an anion sensor
Zeyrek, C. T., Boyacıoğlu, B., Yıldız, M., Ünver, H., Yolal, D., Demir, N., Elmalı, A., Tadesse, S., & Aslan, K. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.018 · Cited by 8
Incidence and Antifungal Susceptibility of Candida Albicans Infections.
Ungureanu, A. M., Găman, A. E., Turculeanu, A., Mitroi, M., Drocaș, A. I., Dobriţoiu, M., Alexandru, D. O., & Vasile, C. M. (2016) · Europe PMC (PubMed Central) · doi:10.12865/chsj.42.02.08 · Cited by 8
Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans
Oliver, B. G., Silver, P. M., & White, T. C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn101 · Cited by 9
Self-citation
Comparative Analysis of Two Candida parapsilosis Isolates Originating from the Same Patient Harbouring the Y132F and R398I Mutations in the ERG11 Gene
Štefánek, M., Garaiová, M., Valček, A., Jordao, L., & Bujdáková, H. (2023) · Cells · doi:10.3390/cells12121579 · Cited by 7
Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors
Morschhäuser, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012643 · Cited by 8
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 7
Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans
Hameed, S., Hans, S., Singh, S., & Fatima, Z. (2019) · Current Drug Discovery Technologies · doi:10.2174/1570163816666190227231437 · Cited by 7
Analytical Concept of Fungicide Resistance: A Review
Sharma, R. (2019) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2019.812.201 · Cited by 7
Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
Lotfali, E., Erami, M., Fattahi, A., Nemati, H., Ghasemi, Z., & Mahdavi, E. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.2.10326 · Cited by 8
Impact of real-time fungal susceptibility on clinical practices
Magiorakos, A.-P., & Hadley, S. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200412000-00002 · Cited by 7
Ligand-Based Drug Discovery Leveraging State-of-the-Art Machine Learning Methodologies Exemplified by Cdr1 Inhibitor Prediction
Trinh, T.-C., Falson, P., Tran‐Nguyen, V., & Boumendjel, A. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00374 · Cited by 7
Anticandidal effect of cinnamic acid characterized from Cinnamomum cassia bark against the fluconazole resistant strains of Candida
Kannan, K. P., & Girija, A. S. S. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01469-w · Cited by 6
An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans
Bruzual, I., & Kumamoto, C. A. (2011) · Molecular Genetics and Genomics · doi:10.1007/s00438-011-0650-z · Cited by 7
Análisis cuantitativo de la expresión de genes de resistencia a fluconazol en cepas de Candida albicans aisladas al ingreso de adultos mayores a una unidad de cuidados intensivos de Manizales, Colombia
Rodríguez, A. E. R., Pérez, J. E., Hernandez, J., & Zapata, Y. (2020) · Biomédica · doi:10.7705/biomedica.4723 · Cited by 6
Interaction of Styrylpyridinium Compound with Pathogenic Candida albicans Yeasts and Human Embryonic Kidney HEK-293 Cells
Vaitkienė, S., Bekere, L., Duburs, G., & Daugelavičius, R. (2020) · Microorganisms · doi:10.3390/microorganisms9010048 · Cited by 6
Formation, Resistance, and Pathogenicity of Fungal Biofilms: Current Trends and Future Challenges
Aguilar-Marcelino, L., Al‐Ani, L. K. T., Soares, F. E. D. F., Moreira, A. L. E., Téllez‐Téllez, M., Castañeda-Ramírez, G. S., Acosta-Urdapilleta, M. D. L., Dı́az-Godı́nez, G., & Pineda-Alegría, J. A. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_18 · Cited by 7
The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections
Reitler, P., Regan, J., DeJarnette, C. A., Srivastava, A., Carnahan, J., Tucker, K. M., Meibohm, B., Peters, B. M., & Palmer, G. E. (2024) · Infection and Immunity · doi:10.1128/iai.00072-24 · Cited by 6
Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
LaFleur, M. D. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010021 · Cited by 6
Caracterización de los mecanismos de resistencia a azoles en aislados clínicos chilenos de Candida albicans
Fuentes, M., Hermosilla, G., Claudio Alburquenque, O., Falconer, M. A., Amaro, J., & Tapia, C. V. (2014) · Revista chilena de infectología · doi:10.4067/s0716-10182014000500001 · Cited by 6
Essential oil composition of Mentha spp. extracted seasonally and their effects against Candida yeast growth and biofilm formation
de Feiria, S. N. B., Sant’Ana, P. D. L., Boni, G., Aníbal, P. C., Boriollo, M., Figueira, G., Sousa, I. D. O., Pereira, B. M. J., Foglio, M. A., & Höfling, J. (2016) · Advancement in Medicinal Plant Research · Cited by 6
Synergistic interactions between β-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans
de Moraes, D. C., de Sá, L. F. R., Domingos, L. T. S., Pinto, M. D. C. F. R., Soares, R. M. D. A., & Ferreira‐Pereira, A. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.002 · Cited by 6
Amino Acid Residues Affecting Drug Pump Function in Candida albicans-C. albicans Drug Pump Function-
Holmes, A. R., Tsao, S., Lamping, E., Niimi, K., Monk, B. C., Tanabe, K., Niimi, M., & Cannon, R. D. (2006) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.47.275 · Cited by 6
Expanding the toolkit for genetic manipulation and discovery in Candida species using a CRISPR ribonucleoprotein-based approachPreprint
Gregor, J. B., Gutierrez-Schultz, V. A., Hoda, S., Baker, K. M., Saha, D., Burghaze, M. G., & Briggs, S. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.16.545382 · Cited by 5
Constraint on boric acid resistance and tolerance evolvability in Candida albicans
Syvolos, Y., Salama, O. E., & Gerstein, A. C. (2024) · Canadian Journal of Microbiology · doi:10.1139/cjm-2023-0225 · Cited by 6
Inhibition of azole-resistant Candida albicans ATPase and oxidoreductase activity by a flavonoid from Dalea elegans
Passero, P., Muthular, M., Barceló, S., Miozza, V. A., & Pérez, C. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101247 · Cited by 5
Bioprospecting Prenyl Flavanones from Dalea boliviana: Structural Insights and Antifungal Properties Against Azole-Resistant Candida albicans
Negro, M. F., Ortega, M. G., & Peralta, M. A. (2024) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-024-00526-7 · Cited by 5
Mutation of G234 amino acid residue inCandida albicansdrug-resistance-related protein Rta2p is associated with fluconazole resistance and dihydrosphingosine transport
Zhang, S., Miao, Q., Li, L., Zhang, L., Yan, L., Jia, Y., Cao, Y., & Jiang, Y. (2015) · Virulence · doi:10.1080/21505594.2015.1051296 · Cited by 5
Fungal infections in the critically ill
Dhillon, R. H., & Clark, J. (2011) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2011.05.007 · Cited by 4
Structure–Function Analyses of Multidrug Transporters
Lamping, E., Madani, G., Lee, H. J., Niimi, M., & Cannon, R. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_18 · Cited by 5
The small GTPase Rhb1 is involved in the cell response to fluconazole inCandida albicans
Chen, Y., Yeh, Y.-C., Chen, H.-F., Chen, R.-C., Lin, G.-Y., Chen, Y.-T., & Lan, C. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz005 · Cited by 5
Inhibitory effects of Allium cepa L. ethanolic extract on biological activities and expression of ERG11 in Candida albicans
Heidary, F., Shams‐Ghahfarokhi, M., & Razzaghi‐Abyaneh, M. (2022) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2022.100535 · Cited by 6
Gingerly effervescent tablets: investigating the effect of cytotoxicity on gingival fibroblasts and antimicrobial properties under laboratory conditions
(2019) · Biointerface Research in Applied Chemistry · doi:10.33263/briac96.5534538 · Cited by 5
In Vitro Activity of Two Nanoparticles on Clinical Isolates of Candida parapsilosis, Showing Resistance Against Antifungal Agents in Children
Lotfali, E., Shahverdi, A. R., Mohammadi, R., Noorbakhsh, F., Ghajari, A., Ansari, S., & Rezaie, S. (2017) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.13853 · Cited by 5
Silver nanoparticles, a promising treatment against clinically important fluconazole‐resistant Candida glabrata
Darwish, R. M., Alkawareek, M. Y., Bulatova, N., & Alkilany, A. M. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13560 · Cited by 5
A State-of-the-art Review and Prospective Therapeutic Applications of Prenyl Flavonoids as Chemosensitizers against Antifungal Multidrug Resistance in Candida albicans
Santi, M. D., Ortega, M. G., & Peralta, M. A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220209103538 · Cited by 5
Yeast strains designed for screening of reversal agents and genetic suppressors of multidrug resistance
Kozovská, Z., Hikkel, I., Sidorova, M., & Šubík, J. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.04.014 · Cited by 5
Tools and Techniques to Study Multidrug Transporters of Yeasts
Shah, A. H., Shukla, S., & Prasad, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-49197-4_12 · Cited by 5
Molecular Detection of Antifungal Resistance
Edlind, T. D. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch44 · Cited by 5
Antifungal and Anti-tyrosinase Activities of Dalea Species Extracts: Differential Biological Effects and Their Correlation with Phytochemical Content via UPLC-MS/MS Profiling
Peralta, M. A., Negro, M. F., Aguirre, E. N. B., Santi, M. D., & Ortega, M. G. (2025) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-025-00641-z · Cited by 4
Formulation and Charaterization of Antifungal Drug Microemulsion Hydrogel for Topical Drug Delivery
Thaker, V., & Tahilani, P. (2022) · Asian Journal of Pharmacy and Technology · doi:10.52711/2231-5713.2022.00017 · Cited by 4
Nystatin Encapsulated Nanoliposomes: Potential Anti-infective against Candida Spp. Isolated from Candidiasis Patients
Asadi, M., Milani, A. T., & Soufiani, K. B. (2024) · Advanced Biomedical Research · doi:10.4103/abr.abr_65_23 · Cited by 4
Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing
Kim, T. H. T., & Lee, M. K. (2010) · Folia Microbiologica · doi:10.1007/s12223-010-0045-2 · Cited by 4
Multidrug- and Cross-Resistant Candida: the Looming Threat
Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4
Synthesis of Altissimacoumarin D and Other Prenylated Coumarins and Their Ability to Reverse the Multidrug Resistance Phenotype in Candida albicans
Silva, A. C., de Moraes, D. C., do Carmo, D. C., Gomes, G. C. C., Ganesan, A., Lopes, R. S. C., Ferreira‐Pereira, A., & Lopes, C. C. (2023) · Journal of Fungi · doi:10.3390/jof9070758 · Cited by 4
Experimental, DFT Calculation, Biological Activity, Anion Sensing Application Studies and Crystal Structure of (E)-4-[(pyridin-3-ylimino)methyl]benzene-1,3-diol
Ünver, H., Boyacıoğlu, B., Zeyrek, C. T., Yolal, D., Yıldız, M., YILDIRIM, N., Demir, N., Kiraz, A., & Elmalı, A. (2018) · Journal of Chemical Crystallography · doi:10.1007/s10870-018-0710-x · Cited by 4
Evolution of antimicrobial drug resistance in human pathogenic fungi
Mir, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00009-7 · Cited by 4
Digoxin Derivatives Sensitize a Saccharomyces cerevisiae Mutant Strain to Fluconazole by Inhibiting Pdr5p
de Moraes, D. C., Tessis, A. C., Rollin‐Pinheiro, R., Princival, J. L., Villar, J. A. F. P., Barbosa, L. A., Barreto‐Bergter, E., & Ferreira‐Pereira, A. (2022) · Journal of Fungi · doi:10.3390/jof8080769 · Cited by 4
Revealing Anti-Microbial Potential of Traditional Siddha Formulation Pancha Karpa Chooranam against Infectious Pathogens
Iyswarya, S., Meena, S., Visweswaran, S., & Muthukumar, N. J. (2023) · Pharmacognosy Research · doi:10.5530/pres.15.2.043 · Cited by 4
Antimycotic Drug Discovery in the Age of Genomics
Cleary, J. D., Walker, L., & Hawke, R. L. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505060-00004 · Cited by 4
TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans
Zheng, H., Jiang, Y., Wang, Y., Jia, X., Yan, T., Gao, P., Yan, L., Jiang, L., Ji, H., & Cao, Y. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.018325-0 · Cited by 4
A CONTRIBUTION TO THE STUDY OF BIOCONTROL AGENTS APITHERAPY AND OTHER POTENTIAL ALTERNATIVES TO ANTIBIOTICS
Alnaimat, S. M. (2011) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 4
Stress-driven emergence of heritable non-genetic drug resistancePreprint
Xie, J. L., Yin, S., Yang, T. S., Chandrasekher, K. A., Hanson, L., Kim, S. H., Esqueda, L., Hogan, C. A., Banaei, N., Round, J. L., et al. (2024) · Research Square · doi:10.1101/2024.12.20.629823 · Cited by 4
Dual inhibition of ERG11 and CDR2 in drug-resistant Candida albicans by Indian phytochemicals: a combined in silico–in vitro approach
Mundhe, A. K., & Rajkumari, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1687392 · Cited by 3
Basal expression of ERG11 , MDR1 and CDR1 genes in clinical isolates of Candida albicans from Ecuador: insights into azole resistance surveillance
Sánchez-Villacreses, E. M., Tapia, J. C., Cáceres-Valdiviezo, M. J., Gabriel Morey-León, G., Fernández‐Cadena, J. C., & Andrade-Molina, D. (2025) · All Life · doi:10.1080/26895293.2025.2551757 · Cited by 3
Emergence and Evolution of Antifungal Resistance
Edlind, T. D. (2014) · ASM Press eBooks · doi:10.1128/9781555815639.ch25 · Cited by 3
Antifungal Mechanisms of Action and Resistance
Perlin, D. S., & Mellado, E. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch34 · Cited by 3
Microbiological and spectrophotometric methods for the determination of tioconazole: A comparative thermodynamic study
Elmasry, M. S., El-Demerdash, A. S., & Sharaf, Y. A. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.122770 · Cited by 3
Yeast Particle Encapsulation of Azole Fungicides for Enhanced Treatment of Azole-Resistant Candida albicans
Soto, E. R., Rus, F., & Ostroff, G. R. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15080203 · Cited by 3
Specific Chromosome Alterations ofCandida albicans: Mechanisms for Adaptation to Pathogenicity
Rustchenko, E. P. (2014) · ASM Press eBooks · doi:10.1128/9781555815639.ch18 · Cited by 3
In vitroandin vivoantifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistantCandida albicans
Takahata, S., Okutomi, T., Ohtsuka, K., Hoshiko, S., Uchida, K., & Yamaguchi, H. (2005) · Medical Mycology · doi:10.1080/13693780410001731600 · Cited by 3
Antifungal Drug Resistance in Developing Countries
Perlin, D. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-89370-9_9 · Cited by 4
ABC and MFS Transporters: A reason for Antifungal drug resistance
Neelabh, D., & Singh, K. (2018) · Archives of Biotechnology and Biomedicine · doi:10.29328/journal.abb.1001009 · Cited by 4
The Evolution of Microbial Defence Systems Against Antimicrobial Agents
Madhav, A., Will, R. C., & Mutreja, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-3658-8_1 · Cited by 3
Population genetics and diversity of the species Brettanomyces bruxellensis : a focus on sulphite tolerance
Avramova, M. (2017) · theses.fr (ABES) · doi:10.70675/f3176fa1z554az4786z8d76z5c8f10d38c07 · Cited by 3
A Combination approach using Areca nut and Ketoconazole for Treating Cutaneous Candidiasis
Wagle, M. M., Lobo, K. N., Rajath Kanchan, R., Chandrashekar, A., & Subrahmanyam, V. M. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00537 · Cited by 2
Management of Scalp Biofilm in Local Dermatosis: From In Vivo Visualization to Optimal Treatments
Joo, J. H., Kim, J. J., Shin, J. Y., Choi, Y.-H., Rim, H., Jun, S., & Kang, N. G. (2024) · Applied Sciences · doi:10.3390/app142110008 · Cited by 4
Transcriptome in Human Mycoses
Peres, N. T. A., Persinoti, G. F., Lang, E. A. S., Rossi, A., & Martinez-Rossi, N. M. (2014) · Springer eBooks · doi:10.1007/978-3-319-11985-4_13 · Cited by 3
A pilot study on ultrashort peptide with fluconazole: A promising novel anticandidal combination
Darwish, R. M., & Salama, A. H. (2023) · Veterinary World · doi:10.14202/vetworld.2023.1284-1288 · Cited by 2
Azoles
Andes, D. R., & Dismukes, W. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_5 · Cited by 3
Mosquitocidal activity against Anopheles arabiensis of plants used as mosquito repellents in South Africa.
Mavundza, E. J. (2014) · Cited by 2
Resistance to Antifungal Agents
Arıkan, S., & Rex, J. H. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0136 · Cited by 2
Spontaneous Suppressors against Debilitating Transmembrane Mutants of CaMdr1 Disclose Novel Interdomain Communication via Signature Motifs of the Major Facilitator Superfamily
Sharma, S., Banerjee, A., Moreno, A., Redhu, A. K., Falson, P., & Prasad, R. (2022) · Journal of Fungi · doi:10.3390/jof8050538 · Cited by 1
Phytochemical characterization and pharmacological evaluation of aerial and root parts of Dalea pazensis Rusby [Fabaceae]
Peralta, M. A., Aguirre, E. N. B., Negro, M. F., Echeverría, J., Santi, M. D., & Ortega, M. G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1717359 · Cited by 1
The activity of micafungin against clinical isolates of non-albicans Candida spp.
Biernasiuk, A., Dobiecka, E., Zdzienicka, G., & Malm, A. (2015) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2015-0033 · Cited by 1
Multidrug Resistance in Fungi: The Role of Pleiotropic Drug Resistance Genes
Sharma, S., & Ganesan, K. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_8 · Cited by 1

Authors: White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A.
Affiliations: Center for Infectious Disease Research (US)
Santa Clara Valley Medical Center (US)
Corresponding author: White, Theodore C.
ORCID: White, Theodore C.
Stevens, David A.
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2002-06
Volume: 46
Issue: 6
Pages: 1704-1713
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.46.6.1704-1713.2002
PMC: PMC127245
OpenAlex: W2117461892
Cited by: 461
References: 42
Citations by year: 2026: 8 · 2025: 9 · 2024: 14 · 2023: 15 · 2022: 24 · 2021: 9 · 2020: 16 · 2019: 28 · 2018: 16 · 2017: 23 · 2016: 22 · 2015: 31 · 2014: 28 · 2013: 19 · 2012: 12
FWCI: 13.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Burroughs Wellcome Fund
M.J. Murdock Charitable Trust
National Institutes of Health
National Institute of Dental and Craniofacial Research (R01DE011367, R01 DE-11367)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida albicans, azole resistance, drug resistance mechanisms, ERG11 mutations, CDR1, CDR2, MDR1, efflux pump overexpression, cross-resistance, fluconazole, clotrimazole, itraconazole, ketoconazole, clinical isolates
MeSH terms: Antifungal Agents, Candida albicans, Candidiasis, DNA, Fungal, Drug Resistance, Microbial, Fungal Proteins, Microbial Sensitivity Tests, Phenotype, Polymorphism, Restriction Fragment Length, RNA, Fungal, Blotting, Southern, Blotting, Northern, DNA Probes, Gene Expression Regulation, Fungal, Drug Resistance, Multiple, ATP-Binding Cassette Transporters, Genes, MDR, Reverse Transcriptase Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Resistance Mechanisms in Clinical Isolates of Candida albicans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks